Mahendrabhai Gulabdas Patel's most recent trade in Lincoln Pharmaceuticals Ltd. was a Acquisition of 33,200 Equity Shares done at an average price of Rs. 299.6 . Disclosure was reported to the exchange on Nov. 18, 2022 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Mahendrabhai Gulabdas Patel's has made SAST transactions in Lincoln Pharmaceuticals Ltd. recently where a Acquisition of 24,000 shares done . Disclosure was reported to the exchange on Sept. 29, 2021.
Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lincoln Pharma | MAHENDRABHAI GULABDAS PATEL | Promoter & Director | Acquisition | 18 Nov 2022 | 33,200 | 608,200 (3.04%) | 0.17% | 299.6 | 9,946,720 | 17 Nov 2022 17 Nov 2022 |
Insider Trading | Equity Shares | Market Purchase |
Lincoln Pharma | Mahendrabhai Gulabdas Patel | Promoter & Director | Acquisition | 29 Sep 2021 | 24,000 | 575,000 (2.88%) | 0.12% | 381.6 | 9,158,880 | 27 Sep 2021 27 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
Lincoln Pharma | Mahendrabhai Gulabdas Patel | Promoter | Acquisition | 29 Sep 2021 | 24,000 | 575,000 (2.88%) | 0.12% | - | 27 Sep 2021 27 Sep 2021 |
SAST (29(2)) | - | Market | |
Lincoln Pharma | Mahendrabhai Gulabdas Patel & PACs | Promoter | Acquisition | 22 Sep 2021 | 39,500 | 551,000 (2.76%) | 0.20% | - | 20 Sep 2021 21 Sep 2021 |
SAST (29(2)) | - | Market | |
Lincoln Pharma | Mahendrabhai Gulabdas Patel | Promoter & Director | Acquisition | 21 Sep 2021 | 35,000 | 551,000 (2.76%) | 0.18% | 383.5 | 13,422,500 | 21 Sep 2021 21 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |
Lincoln Pharma | Mahendrabhai Gulabdas Patel | Promoter & Director | Acquisition | 21 Sep 2021 | 4,500 | 516,000 (2.58%) | 0.02% | 383.3 | 1,724,670 | 20 Sep 2021 20 Sep 2021 |
Insider Trading | Equity Shares | Market Purchase |